72117Ethiqa XR buprenorphine Extended Release I
State & local contract award Virginia Awarded
- Contract number
- A236_P0358315
- Awardee
- COVETRUS NORTH AMERICA
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $422.45
About this award
Virginia Commonwealth University awarded a contract to Covetrus North America on October 5, 2026, for the procurement of pharmaceutical products. The contract, designated A236_P0358315, is valued at $422.45 and involves the delivery of a single unit of Ethiqa XR buprenorphine Extended Release to VCU Procurement. Buprenorphine is a controlled substance commonly used in medication-assisted treatment for opioid use disorder. The award was issued by Virginia Commonwealth University, a state-based contracting organization located in Virginia.
Under this contract, Covetrus North America serves as the prime contractor responsible for delivering the specified pharmaceutical product. The unit price for the Ethiqa XR buprenorphine Extended Release is $422.45. The delivery location is designated as VCU Procurement, indicating the point of performance is within Virginia Commonwealth University's procurement operations. No specific contract period of performance dates beyond the award date are provided in the available documentation.
Line items
| Item | Total |
|---|---|
| 72117Ethiqa XR buprenorphine Extended Release I | $422.45 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0358315?
Contract A236_P0358315 was awarded to COVETRUS NORTH AMERICA by Virginia Commonwealth University on October 5, 2026.
How much is contract A236_P0358315 worth?
Its cumulative value is $422.45.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award